MicroPort Scientific : FOXTROT® NC PTCA Balloon Catheter Gains Regulatory Approval in ...

Mexico City, Mexico - FOXTROT NC PTCA Balloon Catheter ('FOXTROT NC'), in-house developed by Shanghai MicroPort Medical (Group) Co., Ltd. ('MicroPort'), recently received the regulatory approval from the health authority of the Mexican government - the Federal Commission for the Protection against Sanitary Risk (in Spanish, Comisión Federal para la Protección contra Riesgos Sanitarios, COFEPRIS). In previous years, FOXTROT NC had gained the CE mark, and received approvals from Japan's Ministry of Health Labour and Welfare ('MHLW'), US Food and Drug Administration ('FDA') and China Food and Drug Administration ('CFDA'), and it was launched in the Philippines, Thailand and Brazil.

FOXTROT NC is a non-compliant rapid exchange PTCA balloon dilatation catheter. The device features high burst pressure, low compliance and small balloon profile, which lead to its excellent pushability, trackability and crossability. FOXTROT NC is indicated for the balloon catheter dilatation of the stenotic portion of a coronary artery, for the purpose of facilitating the implantation of balloon expandable stents, preventing the edge effects, protecting healthy tissues, as well as improving myocardial perfusion.

Aside from FOXTROT NC, MicroPort's FOXTROT PRO Balloon Dilatation Catheter and Firehawk Rapamycin Target Eluting Coronary Stent System also obtained approval from the COFEPRIS. Dr. Linda Lin, First Vice President of MicroPort International Business, said: 'By offering stent and balloon products used in the percutaneous coronary intervention ('PCI') in the Mexico market, MicroPort is on the way to provide more comprehensive medical solutions for South American patients.'

About MicroPort

MicroPort Scientific Corporation (the 'Group') is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 15 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.

For more information, please refer to: www.microport.com

Forward-Looking Statements

Some information contained on this website contains forward-looking statements. These forward-looking statements include, without limitation, those regarding our future financial position, our strategy, plans, objectives, goals and targets, future developments in the markets where we participate or are seeking to participate, and any statements preceded by, followed by or that include the words 'believe', 'intend', 'expect', anticipate', 'project', 'estimate', 'predict', 'is confident', 'has confidence' and similar expressions are also intended to identify forward-looking statements. Such statements are based upon the current beliefs and expectations of MicroPort's management and are subject to significant risks and uncertainties. MicroPort Scientific Corporation undertakes no obligation to update any of the statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors that could cause actual future results to differ materially from current expectations include, but are not limited to, general industry and economic conditions, PRC governmental policies and regulations relating to the medical device manufacturing industry, competition in the medical device manufacturing industry, our ability to develop new products and stay abreast of market trends and technological advances, our goals and strategies, our ability to execute strategic acquisitions of, investments in or alliances with other companies and businesses, fluctuations in general economic and business conditions in China.

This document is for information purposes only and does not constitute or form part of any offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for any securities of MicroPort Scientific Corporation, and no part of it shall form the basis of, or be relied upon in connection with, any agreement, arrangement, contract, commitment or investment decision in relation thereto whatsoever.

All rights reserved.
Copyright © 2017 MicroPort Scientific Corporation